F, P., V, D. P., G, S., S, M., L, T., & L, Q. (2022). Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia. Frontiers in oncology, 11, 801124. https://doi.org/10.3389/fonc.2021.801124
Chicago Style (17th ed.) CitationF, Piazza, Di Paolo V, Scapinello G, Manni S, Trentin L, and Quintieri L. "Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia." Frontiers in Oncology 11 (2022): 801124. https://doi.org/10.3389/fonc.2021.801124.
MLA (9th ed.) CitationF, Piazza, et al. "Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia." Frontiers in Oncology, vol. 11, 2022, p. 801124, https://doi.org/10.3389/fonc.2021.801124.